PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure

PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure - PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001900

Enrollment

Registered

2009-04-23

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Myeloid Leukemia (chronic phase)

Interventions

Dasatinib

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Imatinib failure above 15 years old PS 0-2

Exclusion criteria

Exclusion criteria: double cancer pregnancy etc

Design outcomes

Primary

Measure	Time frame
MMR rate	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026